The following information is exclusively reserved for physicians practicing in Austria, the Netherlands, Spain, and Switzerland where the Zio™ monitor ECG monitoring service is currently authorised and made available for use in accordance with local regulatory requirements.

Learn more
Search

Transforming Cardiac Monitoring

The iRhythm™ monitoring service, featuring Zio™ ECG monitors, provides the end-to-end solution that’s transforming cardiac monitoring across the globe.

Female physician

Patient-centered design

The pliability of Zio™ ECG monitors allow for a comfortable wear, designed to improve patient compliance and satisfaction.1-3

Curated reports

Zio™ end-of-wear reports are generated by our CE-marked and FDA cleared advanced AI, Zio™ ECG Utilization Service (ZEUS) system and verified by Qualified ECG Specialists (QES).

Anytime accessibility

ZioSuite™ web portal allows you to interpret reports, manage patients, and more from your computer.

Seamless integration

EHR integration service enables you to register patients, receive reports, and order Zio ECG monitors directly through your EHR.8
Physician holding tablet

Delivering precision to cardiology and electrophysiology

The iRhythm monitoring service aims to simplify the cardiac monitoring experience, providing you with highly accurate data you can trust, so you can make the right diagnosis the first time.9-11

  • Remarkable clinical outcomes3,12-18
  • Astounding patient compliance3,17-19 and satisfaction3,20-21
  • Designed to improve ECG interpretation5
  • Help achieve the right diagnosis first time9-11
Learn why
See the proof

Medical Affairs

Our Medical Affairs team partners directly with our customers on clinical science, research ideas, educational opportunities, and grant requests. Browse our collection of offerings.
Discover more

Continue the conversation

The Zio™ service helps you detect arrhythmias earlier, reduce administrative burden, and enhance patient experience — all through a single, streamlined platform.

 

Connect with an iRhythm specialist today to discover how the Zio service can fit into your workflow.

Continue the conversation
Man with child on his shoulders
  1. Zio monitor Instructions for Use. iRhythm Technologies, 2023. 
  2. Battisti et al. Abstract 4141717: Feasibility of point-of-wear patient satisfaction surveys to validate patient-centered product enhancements: results from over 300,000 patients for long-term ambulatory cardiac monitoring. Circulation. 2024;150:A4141717. doi:10.1161/circ.150.suppl_1.4141717. https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4141717 
  3. Based on US data. 
  4. Data on file. iRhythm Technologies, 2020. 
  5. Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. https://doi.org/10.1038/s41591-018-0268-3  
  6. Deep learned algorithm is only available in the United States, European Union, Switzerland, United Kingdom, and Japan.  
  7. FDA 510K clearance, CE mark, UKCA mark, and PMDA-approval. 
  8. Baseline reports, daily reports, and transmission reports are not electronically transmitted from iRhythm to EHR systems. They are available in ZioSuite. 
  9. Data on file. iRhythm Technologies, 2023.  
  10. Based on the US market data using Zio ECG monitors.  
  11. Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report. 
  12. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25–34. https://doi.org/10.1016/j.ahj.2023.12.002 
  13. Diagnostic yield was assessed based upon the evaluation of specified arrhythmias, which refer to an arrhythmia encounter diagnosis as per Hierarchical Condition Categories (HCC) 96. 
  14. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file. 
  15. Zio LTCM service refers to Zio XT and Zio monitor service. 
  16. Contraindications: Do not use the Zio monitor for critical care patients or for patients with symptomatic episodes where instance variations in cardiac performance could result in immediate danger to the patients or when real-time or in-patient monitoring should be prescribed. (Refer to the Zio monitor Instructions for Use for the full list of contraindications.) 
  17. Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report. 
  18. Zio monitor and ZEUS are CE-marked. 
  19. Data on file. iRhythm Technologies, 2022.  
  20. Battisti et al. Abstract 4141717: Feasibility of point-of-wear patient satisfaction surveys to validate patient-centered product enhancements: results from over 300,000 patients for long-term ambulatory cardiac monitoring. Circulation. 2024;150:A4141717. doi:10.1161/circ.150.suppl_1.4141717. https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4141717 
  21. Data on file. iRhythm Technologies, 2024

 

The Zio™ service is a long-term continuous ambulatory cardiac monitoring service. It consists of the Zio™ monitor that collects beat-to-beat ECG data and can be worn for up to 14 days; the Zio™ ECG Utilization Service (ZEUS) System deep learned algorithm, which detects arrhythmias. The data is reviewed and curated by a team of Qualified ECG Specialists (QES) to provide the final patient report.

For indications for use, warnings & contraindications, visit here.

iRhythm, Zio, Zio monitor, and ZioSuite are trademarks of iRhythm Technologies, Inc. ©2024 All rights reserved.

Zio™ monitor and ZEUS are CE-marked (CE2797).

Zio monitor, ZEUS, and Zio service are currently available in Austria, the Netherlands, Spain & Switzerland.

For further regulatory information visit here.

WEB0213.01

Contact us